Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12391753
Antigen binding molecule formats
granted -
US 12391923
SIRPα-silenced natural killer (NK) cells
granted -
US 12391765
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
granted -
US 12391732
Articles comprising a silk polypeptide for antigen delivery
granted -
US 12391920
Models of tauopathy
granted -
WO 2025168072
COMPOSÉS HÉTÉROCYCLIQUES, COMPOSITIONS ASSOCIÉES ET MÉTHODES DE TRAITEMENT ASSOCIÉS
granted -
WO 2025168081
TRAITEMENT D'UN TROUBLE PROLIFÉRATIF DES LYMPHOCYTES B AVEC UN COMPOSÉ ACTIVATEUR DE DÉGRADATION CHIMÉRIQUE
granted -
WO 2025169901
CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE PRÉSENTANT UNE ACTIVITÉ D'INDUCTION DE LA DÉCOMPOSITION DE PROTÉINES MUTANTES KRAS
granted -
US 12385013
Differentiation of pancreatic endocrine cells
granted -
US 12383516
Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
granted -
US 12385026
Stabilized alpha-galactosidase and uses thereof
granted -
US 12385914
CRY1-clock-BMAL1 complex-disrupting agents and methods of identifying and using same
granted -
US 12385043
Modified double-stranded RNA agents
granted -
US 12385012
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 12384854
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
granted -
US 12384817
Peptide having protective activity against cell damage caused by particulate matter, and uses for same
granted -
US 12384829
Pocket engineering of HLA alleles for treating autoimmunity
granted -
US 12384853
Anti-HER2/PD1 bispecific antibody
granted -
US 12384845
Activatable masked anti-CTLA4 binding proteins
granted -
US 12383560
Compounds and uses thereof
granted -
US 12383540
Compounds that modulates AMPA receptor function
granted -
US 12383535
Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor
granted -
US 12383522
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 12383567
Use of cannabinoids in the treatment of epilepsy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.